Both in Pharmaceuticals
Alkermes vs Axsome Therapeutics
Over the past year ALKS returned +54.2% and AXSM returned +4.7%; their daily moves had a correlation of 0.32.
ALKS +54.2% AXSM +4.7%Growth of $1, one year, split-adjusted
| Metric | ALKS | AXSM |
|---|---|---|
| Price | $46.52 | $142.17 |
| Market cap | $7.80B | $7.45B |
| Today | +3.63% | +4.53% |
| 1 month | +8.8% | −19.7% |
| 6 months | +28.3% | −36.3% |
| Year to date | +66.3% | −22.2% |
| 1 year | +51.5% | +5.3% |
| Revenue growth (YoY) | +27.0% | +51.9% |
| Gross margin | 80.2% | 93.1% |
| Net margin | 0.1% | −5.0% |
| P/E (TTM) | 118.0× | — |
| Price / sales | 4.7× | 8.6× |
| Net cash | -$846.5M | $116.6M |
| Dividend yield | — | — |
| Volatility (60d) | 32.4% | 38.9% |
| Short % of float | 11.5% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).